HOME >> BIOLOGY >> NEWS
Factors affecting kernel yield in maize

1-4 genes, were investigated by examining the impact of knock-out mutations on kernel yield. GS gene expression was impaired in the mutants, resulting in reduced levels of GS1 protein and activity. The gln1-4 phenotype displayed reduced kernel size whereas gln1-3 had reduced kernel number, and both phenotypes were evident in the gln1-3 gln1-4 double mutant. Shoot biomass production at maturity was not affected in either the single mutants or double mutants, suggesting that both gene products play a specific role in grain production. Levels of asparagine increased in the leaves of the mutants during grain filling, most likely as a mechanism for circumventing toxic ammonium buildup resulting from abnormally low GS1 activity. Phloem sap analysis revealed that, unlike glutamine, asparagine is not efficiently transported to developing maize kernels, which could account for the reduced kernel production in the mutants. Constitutive overexpression of Gln1-3 in maize leaves resulted in a 30% increase in kernel number relative to wild type, providing further evidence that GS1 plays a major role in kernel yield.

Some of the major cereals, such as maize, sorghum, and sugar cane, exhibit C4 photosynthesis, which enhances the efficiency of photosynthesis at high temperature (most C4 plants originated in tropical climates). In standard C3 photosynthesis (present in rice, wheat, and most temperate crop plants), CO2 entering the leaf is converted to a 3-carbon compound via the C3 pathway, utilizing energy derived from the light reactions of photosynthesis. In plants that have C4 photosynthesis, the C3 pathway enzymes are localized in specialized bundle sheath cells which surround the vascular tissue in the interior of the leaf. CO2 entering mesophyll cells at the leaf surface initially is converted to a 4-carbon compound, which is shuttled into the bundle sheath cells and then decarboxylated to release CO2. CO2 released into bundle sheath cells then enters the standard
'"/>

Contact: Nancy Eckardt
neckardt@aspb.org
970-495-9918
American Society of Plant Biologists
6-Dec-2006


Page: 1 2 3

Related biology news :

1. Impressive new Impact Factors for BioMed Centrals open-access journals
2. Creating new life forms that may help eradicate cancer affecting women
3. Kansas State study finds new vaccine effective against deadly viral disease affecting swine
4. UMass Lowell research shows benefits of apple juice on neurotransmitter affecting memory
5. CHAVI announces international search for genes affecting HIV response
6. More than drought affecting wheat yields
7. Lost forest yields several new species
8. Natures secrets yield new adhesive material
9. Sequencing method yields fuller picture
10. Modified mushrooms may yield human drugs
11. St. Jude study yields secrets of chromosome movement

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Factors affecting kernel yield maize

(Date:8/26/2015)... The report "Multi-Factor Authentication (MFA) Market ... (Travel & Immigration, Government, Banking, Defense, Commercial Security, Consumer ... published by MarketsandMarkets, Multi-Factor Authentication Market is expected to ... CAGR of 17.7% between 2015 and 2020. ... spread through 169 P ages and ...
(Date:8/24/2015)... CAPE TOWN, South Africa , August 24, 2015 /PRNewswire/ ... awarded Germany ,s largest biometrics manufacturer DERMALOG ... with the "2015 African Biometrics Company of the ... installation in Nigeria .   ... ) and http://www.presseportal.de/nr/8896 - On Thursday ...
(Date:8/20/2015)... Aug. 20, 2015 The wearable technology ... are active and healthy. However, wearable technology has ... environment to help improve diagnostic capabilities and therapeutic ... the Wearable Technologies Conference 2015 , where ... for wearables in healthcare.    "Over ...
Breaking Biology News(10 mins):Multi-Factor Authentication Market Worth 9.60 Billion USD by 2020 2Multi-Factor Authentication Market Worth 9.60 Billion USD by 2020 3Multi-Factor Authentication Market Worth 9.60 Billion USD by 2020 4Multi-Factor Authentication Market Worth 9.60 Billion USD by 2020 5Frost & Sullivan Honors DERMALOG with Biometrics Prize for Achievements in Africa 2Frost & Sullivan Honors DERMALOG with Biometrics Prize for Achievements in Africa 3Leaf Healthcare Releases Video from Wearable Technology Conference on New Applications for Wearables in the Hospital Environment 2Leaf Healthcare Releases Video from Wearable Technology Conference on New Applications for Wearables in the Hospital Environment 3
(Date:8/26/2015)... - iCo Therapeutics ("iCo" or "the Company") (TSX-V: ICO) ... quarter ended June 30, 2015. Amounts, unless specified ... under International Financial Reporting Standards ("IFRS"). ... Oral Amp B program, rapidly advancing towards the ... Rae , President & CEO of iCo Therapeutics. "We ...
(Date:8/26/2015)... ... August 26, 2015 , ... Lee Biosolutions, a global ... and manufacture of highly valued cardiac markers used in early detection of heart ... protein chemistry has led to the development and commercialization of important cardiac biomarkers ...
(Date:8/26/2015)... , Aug. 26, 2015  Platform therapeutic company ... has received a $1.5M Phase II SBIR grant ... further develop its therapeutic agent to reduce arteriovenous ... in end stage renal disease (ESRD) patients undergoing ... Institute of Diabetes and Digestive and Kidney Diseases ...
(Date:8/26/2015)... and BEIJING , August 26, 2015 ... Scene with Impressive Acheivements  DiaCardio wins 1 st ... The competition, led in Israel ... featured 21 startups from countries including the US, China ... and Latin America .  Impressive ...
Breaking Biology Technology:iCo Therapeutics Announces Second Quarter 2015 Financial Results 2iCo Therapeutics Announces Second Quarter 2015 Financial Results 3Lee Biosolutions Announces Increased Investment in the Development and Manufacturing of Biomarkers Used in Early Detection Of Heart Disease 2Symic Biomedical Awarded $1.5MM NIH Phase II SBIR Grant to Develop its Proteoglycan Mimetic Therapeutics to Reduce Vascular Access Failures in ESRD 2Symic Biomedical Awarded $1.5MM NIH Phase II SBIR Grant to Develop its Proteoglycan Mimetic Therapeutics to Reduce Vascular Access Failures in ESRD 3Israeli Startup Takes First Place at Shengjing Global Innovation Awards 2015 2Israeli Startup Takes First Place at Shengjing Global Innovation Awards 2015 3Israeli Startup Takes First Place at Shengjing Global Innovation Awards 2015 4Israeli Startup Takes First Place at Shengjing Global Innovation Awards 2015 5Israeli Startup Takes First Place at Shengjing Global Innovation Awards 2015 6
Cached News: